Skip to main content
SpringerLink
Log in

Tolterodine

A Viewpoint by Paul Abrams

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yarker YE, Goa KG, Fitton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in detrusor instability. Drugs Aging 1995; 6(3): 243–62

    Article  PubMed  CAS  Google Scholar 

  2. Kelleher CJ, Cardozo LD, Khullar V, et al. A medium term analysis of the subjective efficacy treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997; 104: 988–93

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Southmead Hospital, Bristol Urological Institute, Bristol, England

    Paul Abrams

Authors
  1. Paul Abrams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abrams, P. Tolterodine. Drugs 55, 821 (1998). https://doi.org/10.2165/00003495-199855060-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199855060-00009

Search

Navigation